T1	HMM 1431 1607	death within 60 days (primary outcome), survival, cardiovascular events, performance status, quality of life (QOL), symptoms, number of nonstatin medications, and cost savings.
T2	HMM 1753 1766	Mean (SD) age
T3	HMM 2093 2102	Total QOL
T4	HMM 2232 2253	cardiovascular events
T5	HMM 2321 2338	Mean cost savings
T6	HMM 2530 2630	improved QOL, use of fewer nonstatin medications, and a corresponding reduction in medication costs.
